Showing results (701-710 of 3,789) with videos related to
Sort By:
Pageof 379
Oncoimmunology|October 21, 2016
mRNA-transfected dendritic cell vaccine in combination with metronomic cyclophosphamide as treatment for patients with advanced malignant melanomaTroels Holz Borch, Lotte Engell-Noerregaard, Trine Zeeberg Iversen, et al.Oncoimmunology|October 21, 2016
Repurposing platinum-based chemotherapies for multi-modal treatment of glioblastomaNathan B Roberts, Aniket S Wadajkar, Jeffrey A Winkles, et al.Oncoimmunology|October 21, 2016
Intratumoral accumulation of podoplanin-expressing lymph node stromal cells promote tumor growth through elimination of CD4+ tumor-infiltrating lymphocytesAikaterini Hatzioannou, Saba Nayar, Anastasios Gaitanis, et al.Oncoimmunology|October 21, 2016
Highly efficient IL-21 and feeder cell-driven ex vivo expansion of human NK cells with therapeutic activity in a xenograft mouse model of melanomaMarkus Granzin, Ana Stojanovic, Matthias Miller, et al.Oncoimmunology|October 21, 2016
Adoptively transferred natural killer cells maintain long-term antitumor activity by epigenetic imprinting and CD4+ T cell helpJing Ni, Oliver Hölsken, Matthias Miller, et al.Oncoimmunology|February 6, 2014
Clarifying the pharmacodynamics of tecemotide (L-BLP25)-based combination therapyChiao-Jung Kao, Gregory T Wurz, Andreas Schröder, et al.Oncoimmunology|February 6, 2014
Immunological responses to a multi-peptide vaccine targeting cancer-testis antigens and VEGFRs in advanced pancreatic cancer patientsRyuji Okuyama, Atsushi Aruga, Takashi Hatori, et al.Oncoimmunology|February 6, 2014
When breast cancer cells start to fend the educational process of NK cells offEmilie Mamessier, Charlotte Bourgin, Daniel OliveOncoimmunology|February 6, 2014
Characteristics of tertiary lymphoid structures in primary cancersJérémy Goc, Wolf-Herman Fridman, Catherine Sautès-Fridman, et al.Pageof 379